How Do We Evaluate Technologies That Are Not Cost Effective at Zero Price?
Abstract
This article describes why some technologies may fail to demonstrate cost effectiveness even when the acquisition price is set to zero, and why the evaluation of these technologies raises both methodological and ethical questions for HTA agencies.
Authors
Sarah Davis Ron Akehurst